Comparison of Treatments in Diabetic Macular Edema - Trial NCT05715385
Access comprehensive clinical trial information for NCT05715385 through Pure Global AI's free database. This Phase 4 trial is sponsored by Babasaheb Ambedkar Memorial Hospital and is currently Completed. The study focuses on Diabetic Macular Edema. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Babasaheb Ambedkar Memorial Hospital
Timeline & Enrollment
Phase 4
Nov 01, 2014
Oct 01, 2015
Primary Outcome
Change in visual acuity in laser photocoagulation group,Change in visual acuity in bromfenac group,Change in visual acuity in observation group
Summary
Prospective or cohort study to compare the effects of grid macular laser, topical bromfenac
 0.09% and placebo (carboxymethyl cellulose 0.5%) medication in diabetic macular edema.
 
 60 eyes with macular edema of two types i.e. cystoid macular edema (CME) and clinically
 significant macular edema (CSME) were divided into three groups with 20 patients in each
 group. One group was treated with grid laser photocoagulation, the second group was treated
 with topical bromfenac 0.09% drops two times a day and the third group was treated with
 topical carboxy methyl cellulose 0.5% three times a day (placebo treatment).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05715385
Non-Device Trial